SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056208
Filing Date
2021-11-10
Accepted
2021-11-10 16:16:27
Documents
43
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20210930.htm   iXBRL 10-Q 1315452
2 EX-31.1 evok-ex311_6.htm EX-31.1 9583
3 EX-31.2 evok-ex312_8.htm EX-31.2 9866
4 EX-32.1 evok-ex321_7.htm EX-32.1 5044
5 EX-32.2 evok-ex322_9.htm EX-32.2 5262
6 GRAPHIC g3qlaocadqly000001.jpg GRAPHIC 47605
  Complete submission text file 0001564590-21-056208.txt   4080274

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA evok-20210930.xsd EX-101.SCH 32661
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20210930_cal.xml EX-101.CAL 25742
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20210930_def.xml EX-101.DEF 90413
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20210930_lab.xml EX-101.LAB 229602
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20210930_pre.xml EX-101.PRE 169938
12 EXTRACTED XBRL INSTANCE DOCUMENT evok-10q_20210930_htm.xml XML 558294
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 211396845
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences